+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Detailed electrical analysis of lead failures in a small-scaled right ventricular defibrillator lead: reality of Sprint Fidelis medical device recalls



Detailed electrical analysis of lead failures in a small-scaled right ventricular defibrillator lead: reality of Sprint Fidelis medical device recalls



Hellenic Journal of Cardiology 51(3): 219-225



This paper illustrates our experience with the Sprint Fidelis lead (SF, single coil model 6931). We investigated lead failure incidence, analysed for possible predictive factors and examined the efficacy of integrated early ICD warning systems. We analysed 181 consecutive patients with SF (follow up: 406 +/- 250 days). Left ventricular ejection fraction, age, gender, follow up, ICD indication, type of device, duration of implantation, and target vein used for implantation were evaluated as potential predictive factors of lead failure. Additionally, the predictive value of recommended impedance alert adaptations, the potential effects of the sensing integrity counter (SIC), and of the new lead integrity alert (LIA)(R) were studied. Nine lead failures were identified. Lead failure occurred significantly more often in patients with single- and dual-chamber devices. None of the patients under cardiac resynchronisation therapy (CRT) had a lead failure (p=0.04). Seven failures (78%) became apparent through inappropriate shock interventions. Impedance alert adaptations did not prevent any inappropriate shock intervention, but the SIC and the activation of the LIA might have prevented inappropriate interventions. A fractured pace/sense ring conductor was identified as the most vulnerable part of the SF lead (in 7 failures, 78%). We verified an increased failure rate in patients with the SF lead. Only patients with CRT devices were free from lead failure, suggesting a correlation with increased physical activity. The impedance alert reprogramming did not predict any inadequate shock interventions but LIA may become a new valuable tool for the early detection of lead failure signs.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052512846

Download citation: RISBibTeXText

PMID: 20515854


Related references

A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure. Archives of Cardiovascular Diseases 105(4): 203-210, 2012

Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead. Heart Rhythm 9(9): 1446-1451, 2012

Decrease of the right ventricular electrogram amplitude in a Sprint Fidelis shock lead: a sign of lead malfunction?. Europace 14(12): 1758, 2012

Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead. Journal of Interventional Cardiac Electrophysiology 54(2): 161-170, 2019

Sensing failure associated with the Medtronic Sprint Fidelis defibrillator lead. Journal of Cardiovascular Electrophysiology 19(3): 270-274, 2008

Comparison of Sprint Fidelis and Riata defibrillator lead failure rates. International Journal of Cardiology 168(2): 848-852, 2013

Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Archives of Cardiovascular Diseases 104(6-7): 388-395, 2011

Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. Journal of the American College of Cardiology 56(8): 646-650, 2010

Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 6(5): 605-610, 2009

Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. Journal of the American College of Cardiology 57(5): 635-636, 2011

Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. Europace 13(9): 1292-1298, 2011

The higher than expected early failure rate of the Sprint Fidelis implantable cardioverter defibrillator lead (model 6949, Medtronic, Inc.). Heart Rhythm 5(1): 167-8; Author Reply 168, 2008

Long-term performance of the Medtronic Sprint Fidelis lead: a matter of lead type?. Europace 14(11): 1620-1623, 2012

Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads. Circulation. Arrhythmia and Electrophysiology 6(6): 1169-1177, 2013

Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death. Europace 19(12): 2007-2014, 2017